期刊文献+

肿瘤坏死因子凋亡诱导配体蛋白对前列腺癌及膀胱癌细胞抑制作用的研究 被引量:2

Study of the inhibitory action of TRAIL on the prostate cancer cell and bladder cancer cell
原文传递
导出
摘要 目的研究重组并纯化的肿瘤坏死因子凋亡诱导配体蛋白(TRAIL)对前列腺癌(PC-3)及膀胱癌细胞(5637)的抑制作用。方法 PC-3和5637细胞分为对照组(仅加培养液)和实验组(加入40 ng/ml的TRAIL蛋白处理),细胞培养12 h后加入TRAIL蛋白,24 h后应用PCR、Western blot技术检测细胞内抗凋亡蛋白Bcl-2及凋亡信号通路中Caspase-3和Caspase-8基因和蛋白的表达。结果应用SPSS统计分析软件,组间比较采用t检验,结果显示:PC3和5637细胞在TRAIL蛋白作用24 h后Bcl-2基因和蛋白表达水平均降低,而Caspase-8、Caspase-3基因和蛋白表达则增加。与对照组相比,其差异具显著性意义。结论 TRAIL蛋白通过下调抗凋亡基因Bcl-2的表达,增强Caspase-8、Caspase-3的表达从而诱导两种肿瘤细胞的凋亡达到抑癌效应。 ObjectiveThe purpose of this study is to observe the inhibitory action of recombinant and purified TRAIL in the prostate cancer (PC3) and bladder cancer cell (5637).MethodsThe PC3 and 5637 cell lines were divided into control group (only with medium) and experimental group (with 40 ng/ml TRAIL). The TRAIL protein was added in medium after the cells were cultured for 12 hin vitro. For 24 h, real-time PCR and Western blot analysis were used to investigate the genes and protein expression of Bcl-2, Caspase-3 and Caspase-8.Results All data are analyzed by two-tailed Student’st-test using SPSS software. Results revealed that the expression of Bcl-2 decreased while the expression of Caspase-8, Caspase-3 increased in PC3 and 5637 cell lines with TRAIL for 24 h. Compared with the control group, the results had significant differences.ConclusionRecombinant and purified TRAIL induced apoptosis of two kinds of tumor cells to reach the antitumor effect through down-regulating the expression of anti-apoptosis gene Bcl-2 and increasing the expression of apoptosis genes Caspase-8, Caspase-3.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第24期89-91,共3页 Chinese Journal of Clinicians(Electronic Edition)
基金 国家自然科学基金(81272557)
关键词 TNF相关凋亡诱导配体 前列腺肿瘤 细胞凋亡 膀胱癌 TNF-related apoptosis-inducing ligand Prostatic neoplasms Apoptosis Bladder cancer
  • 相关文献

参考文献16

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CACancer J Clin, 2012, 62(1): 10-29.
  • 2Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines onnon-muscle-invasive urothelial carcinoma of the bladder: Update2013[J]. Eur Urol, 2013, 64(4): 639-653.
  • 3Griffith TS, Chin WA, Jackson GC, et al. Intracellular regulation ofTRAIL-induced apoptosis in human melanoma cells[J]. J Immunol,1998, 161(6): 2833-2840.
  • 4Jeremias I, Debatin KM. TRAIL induces apoptosis and activation ofNFkappaB[J]. Eur Cytokine Netw, 1998, 9(4): 687-688.
  • 5刘转转,郝林,范涛,贺厚光,尤红娟,汤仁仙,韩从辉.人TRAIL基因原核表达载体的构建及鉴定[J].现代生物医学进展,2011,11(7):1220-1223. 被引量:4
  • 6郝林,刘转转,贺厚光,范涛,尤红娟,汤仁仙,韩从辉.人肿瘤坏死因子相关凋亡诱导配体胞外区基因原核系统的表达与纯化[J].中华实验外科杂志,2011,28(7):1047-1047. 被引量:4
  • 7Wang S. The promise of cancer therapeutics targeting theTNF-related apoptosis-inducing ligand and TRAIL receptorpathway[J]. Oncogene, 2008, 27(48): 6207-6215.
  • 8Sayers TJ. Targeting the extrinsic apoptosis signaling pathway forcancer therapy[J]. Cancer Immunol Immunother, 2011, 60(8):1173-1180.
  • 9Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer[J].Cytokine Growth Factor Rev, 2008, 19(3/4): 325-331.
  • 10Schrantz N, Blanchard DA, Mitenne F, et al. Manganese inducesapoptosis of human B cells: Caspase-dependent cell death blocked byBcl-2[J]. Cell Death differ, 1999, 6(5): 445-453.

二级参考文献32

  • 1王军,于雯华,康舒里,肖庚富.重组可溶性人TRAIL抑制肿瘤细胞增殖[J].武汉大学学报(理学版),2005,51(4):467-471. 被引量:3
  • 2刘洪波,范学工,李宁,黄建军,朱才.可溶性GS-TrhTRAIL_(55-281)最佳表达条件及凋亡活性研究[J].生命科学研究,2005,9(3):267-271. 被引量:6
  • 3Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family[J]. J Biol Chem, 1996, 271 (22): 12687-90.
  • 4Secchiero P, Vaccarezza M, Gonelli A, et al. TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies [J]. Curr Pharm Des, 2004, 10(29): 3673- 3681.
  • 5Wiley SR, Schooley K. Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity, 1995, 3(6): 673-682.
  • 6Almer M, vander Sloot, Vicente Tur, et al. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor. PNAS[J]. 2006, 103:8634-8639.
  • 7MP Simons, WM Nauseef, TS Griffith. et al. insights into BCG immunotherapy for bladder cancer [J]. Immunol Res, 2007,39 (1-3): 79-93.
  • 8Dorsey JF, Mintz A, Tian XB, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells [J]. Mol Cancer Ther, 2009, 8:3285-3295.
  • 9Dmitri V, Rozanov, Alexei Y, et al. Engineering a leucine zipper- TRAIL homotrimer with improved cytotoxicity in tumor cells[J]. Mol Cancer Ther, 2009, 8:1515-1525.
  • 10Mitchell RS, Fang J, Indira J. Bortezomib Sensitizes Non-Hodgkin's Lymphoma Cells to Apoptosis Induced by Anti bodies to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptors TRAIL-R1 and TRAIL-R2 [J]. Clin Cancer Res, 2007,13: 5528-5534.

共引文献6

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部